| Jennifer Lynn Makosky, MD | |
|
5770 S 250 E, Suite 290, Murray, UT 84107-8100 | |
| (801) 747-8700 | |
| (801) 747-8701 |
| Full Name | Jennifer Lynn Makosky |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 5770 S 250 E, Murray, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073767463 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 7471297-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Lynn Makosky, MD 5770 S 250 E, Suite 290, Murray, UT 84107-8100 Ph: (801) 747-8700 | Jennifer Lynn Makosky, MD 5770 S 250 E, Suite 290, Murray, UT 84107-8100 Ph: (801) 747-8700 |
News Archive
Decisions to withdraw life support treatments in critically ill patients with severe brain injury are complicated, are based on many factors, and are usually made by critical care physicians and families in the intensive care unit.
Studies have shown positron emission tomography's (PET) value as a minimally invasive, painless and safe diagnostic tool for many pediatric conditions. In a study published in the February issue of The Journal of Nuclear Medicine (JNM), researchers at the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania (Penn) gathered data that may provide clinicians with new formulas-specific to pediatrics-to calculate the amount of radiotracer that should be injected based on the patient's weight.
As the back-to-school rush begins, podiatry experts at the University of South Australia are encouraging parents to get their children's school shoes professionally fitted, as new research confirms that ill-fitted footwear can significantly impede foot movement and comfort.
Enzo Biochem, Inc. announced today that its Enzo Clinical Lab division has entered into an exclusive marketing partnership covering the States of New York and New Jersey with privately-owned Ikonisys, Inc., of New Haven, CT, relating to Ikonisys' proprietary oncoFISH® cervical test, a laboratory developed test for cervical cancer prevention.
There's a new treatment option available for patients with AL amyloidosis: daratumumab. Studied in a prospective clinical trial, only one of the two clinical trials of this agent in AL amyloidosis worldwide, researchers have found this anti-cancer drug to be well tolerated and effective in patients with relapsed AL amyloidosis when used with appropriate pre- and post-infusion medications.
› Verified 9 days ago
Dale L Chapman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Dr. Paul E Wirkus, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Dr. John B Wall, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Jake C Jones, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Joseph A Roberts, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 164 E 5900 S, Ste A112, Murray, UT 84107 Phone: 801-262-2673 Fax: 801-269-9894 | |
Dr. Gary Warren Schlichter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 164 E 5900 S, Ste. A112, Murray, UT 84107 Phone: 801-262-2673 Fax: 801-269-9894 |